Related Content
Search Google Scholar for:
|
|
Science 23 May 1986: Vol. 232. no. 4753, pp. 998 - 1001 DOI: 10.1126/science.3010461
|
|
Articles
Science, Vol 232, Issue 4753, 998-1001
Copyright © 1986 by American Association for the Advancement of Science
AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts
JA Levy,
C Cheng-Mayer,
D Dina,
and
PA Luciw
A molecular clone of the AIDS-associated retrovirus (ARV-2) was transfected into human T lymphocyte and monocyte cell lines as well as mouse, mink, monkey, and human fibroblast lines. A replicating virus with cytopathic and biologic properties of ARV-2 was recovered from all the cell lines. The animal and human fibroblast cells are resistant to direct infection by ARV, and in these experiments virus production in the fibroblast lines, especially mouse, was reduced compared to human lymphocytes. However, human fibroblasts were more permissive to virus expression than mouse cells. These results show that, whereas the primary block to ARV infection in certain cells may occur at the cell surface, intracellular mechanisms can also participate in controlling virus replication. The results have relevance to vaccine development and encourage further work with modified molecular clones to examine regions of the ARV genome necessary for cytopathology and replication.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.
- M. J. Potash, W. Chao, G. Bentsman, N. Paris, M. Saini, J. Nitkiewicz, P. Belem, L. Sharer, A. I. Brooks, and D. J. Volsky (2005)
PNAS
102, 3760-3765
| Abstract »
| Full Text »
| PDF »
- Induction of Rapid and Extensive beta -Chemokine Synthesis in Macrophages by Human Immunodeficiency Virus Type 1 and gp120, Independently of Their Coreceptor Phenotype.
- W. Choe, D. J. Volsky, and M. J. Potash (2001)
J. Virol.
75, 10738-10745
| Abstract »
| Full Text »
| PDF »
- Susceptibility of Rat-Derived Cells to Replication by Human Immunodeficiency Virus Type 1.
- O. T. Keppler, W. Yonemoto, F. J. Welte, K. S. Patton, D. Iacovides, R. E. Atchison, T. Ngo, D. L. Hirschberg, R. F. Speck, and M. A. Goldsmith (2001)
J. Virol.
75, 8063-8073
| Abstract »
| Full Text »
| PDF »
- Broadening of coreceptor usage by human immunodeficiency virus type 2 does not correlate with increased pathogenicity in an in vivo model.
- M. E. van der Ende, C. Guillon, P. H. M. Boers, R. A. Gruters, P. Racz, K. Tenner-Racz, A. D. M. E. Osterhaus, and M. Schutten (2000)
J. Gen. Virol.
81, 507-513
| Abstract »
| Full Text »
- The Role of Nucleocapsid and U5 Stem/A-Rich Loop Sequences in tRNA3Lys Genomic Placement and Initiation of Reverse Transcription in Human Immunodeficiency Virus Type 1.
- Y. Huang, A. Khorchid, J. Gabor, J. Wang, X. Li, J.-L. Darlix, M. A. Wainberg, and L. Kleiman (1998)
J. Virol.
72, 3907-3915
| Abstract »
| Full Text »
| PDF »
- Differential effects of nef on HIV replication: implications for viral pathogenesis in the host.
- C Cheng-Mayer, P Iannello, K Shaw, P. Luciw, and J. Levy (1989)
Science
246, 1629-1632
| Abstract »
| PDF »
- The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.
- J Homsy, M Meyer, M Tateno, S Clarkson, and J. Levy (1989)
Science
244, 1357-1360
| Abstract »
| PDF »
- Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats.
- J Overbaugh, P. Donahue, S. Quackenbush, E. Hoover, and J. Mullins (1988)
Science
239, 906-910
| Abstract »
| PDF »
- Immunology of Human Immunodeficiency Virus Infection and the Acquired Immunodeficiency Syndrome: An Update.
- M. SELIGMANN, A. J. PINCHING, F. S. ROSEN, J. L. FAHEY, R. M. KHAITOV, D. KLATZMANN, S. KOENIG, N. LUO, J. NGU, G. RIETHMULLER, et al. (1987)
Ann Intern Med
107, 234-242
| Abstract »
| PDF »
|
|